Immunai

aid: immunai
name: Immunai
description: Immunai is a New York-headquartered biotechnology company, founded in December 2018, that maps the human immune
  system at single-cell resolution and applies machine learning to drug discovery and development. Its central asset is AMICA
  (Annotated Multiomic Immune Cell Atlas), a cell-level immune knowledge base built from single-cell multiomics — RNA transcriptome,
  surface proteome, TCR/BCR repertoire and spatial transcriptomics — harmonized across thousands of public and proprietary
  studies covering hundreds of diseases and immune cell types, paired with an ImmunoDynamics Engine used for target discovery,
  preclinical evaluation and clinical trial optimization. Immunai works through partnerships with biopharmaceutical companies
  and research institutions rather than a self-serve product, and as of this profile it publishes no public developer portal,
  API documentation, machine-readable specification or SDKs. Offices are in New York, Tel Aviv, Prague and Zurich; the company
  acquired Dropprint Genomics (2021) and Nebion (2021).
image: https://www.immunai.com/wp-content/uploads/2022/06/Social.png
url: https://raw.githubusercontent.com/api-evangelist/immunai/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-harvest-source: https://forgeglobal.com/immunai_stock/
x-tier: stub
x-tier-reason: no-public-api-surface
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Biotechnology
- Immunology
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Single-Cell Genomics
- Multiomics
- Clinical Trials
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-discovery:
  date: '2026-08-04'
  result: no-public-api-surface
  probed:
  - 'REST OpenAPI/Swagger on immunai.com, www.immunai.com and fourteen candidate API/docs subdomains (/openapi.json, /openapi.yaml,
    /swagger.json, /v1/openapi.json, /api-docs, /docs, /redoc): 404 on every resolving host, NXDOMAIN on the rest'
  - 'GraphQL: no /graphql surface on any resolving host'
  - 'MCP: no public server. www.immunai.com/wp-json exposes a WordPress mcp-adapter namespace (/wp-json/mcp/mcp-adapter-default-server,
    /wp-json/mcp/mcp-oauth-server) but tools/list returns HTTP 401 rest_forbidden / mcp_unauthorized, and /wp-json/wp-abilities/v1/abilities
    returns 401 — CMS-admin plugin tooling, not a product MCP server'
  - 'A2A: /.well-known/agent-card.json and /.well-known/agent.json both 404 on every reachable host'
  - 'Packages: no first-party library on npm, PyPI, RubyGems or Packagist; no github.com/immunai org (404)'
  - 'llms.txt: 404 on www.immunai.com'
  - api.immunai.com and app.immunai.com DO resolve (34.110.128.250 and 34.144.219.193, both Google Cloud) but neither serves
    Immunai — the first resets the TLS handshake before presenting a certificate, the second presents a certificate for the
    unrelated domain *.asa.com.br and then returns 403. Recorded as dangling DNS records in security/immunai-domain-security.yml,
    not as API hosts
  - Acquired properties nebion.com and genevestigator.com still resolve (95.216.38.13) but no HTTP or HTTPS service answers
    — offline, not deregistered
  - The only public machine-readable surface is the marketing site's stock WordPress REST API at www.immunai.com/wp-json —
    incidental CMS infrastructure, deliberately not registered as an Immunai API
  - 'Security/compliance: no security.txt, no vulnerability disclosure policy, no trust center, no published certification.
    The privacy policy names GDPR/CPRA/Israeli PPL/Swiss FADP and claims Data Privacy Framework participation — captured in
    conformance/immunai-conformance.yml'
common:
- type: DomainSecurity
  url: security/immunai-domain-security.yml
- type: Conformance
  url: conformance/immunai-conformance.yml
- type: LLMsTxt
  url: llms/immunai-llms.txt
- type: Website
  url: https://www.immunai.com/
- type: About
  url: https://www.immunai.com/company/
- type: Product
  url: https://www.immunai.com/platform/
- type: Solutions
  url: https://www.immunai.com/solutions/
- type: Partners
  url: https://www.immunai.com/collaboration/
- type: Careers
  url: https://www.immunai.com/careers/
- type: Contact
  url: https://www.immunai.com/contact/
- type: Blog
  url: https://www.immunai.com/resources/
- type: BlogFeeds
  url: https://www.immunai.com/feed/
- type: PressReleases
  url: https://www.immunai.com/category/press-releases/
- type: Research
  url: https://www.immunai.com/category/publications/
- type: Podcasts
  url: https://www.immunai.com/category/podcasts/
- type: Videos
  url: https://www.immunai.com/category/video/
- type: PrivacyPolicy
  url: https://www.immunai.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/immunai/
- type: Twitter
  url: https://twitter.com/Immunaitech
- type: Youtube
  url: https://www.youtube.com/channel/UC4RFLZLSaNvIkbgyJY2hncw